{"id":2179,"date":"2025-03-24T13:41:22","date_gmt":"2025-03-24T13:41:22","guid":{"rendered":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/?p=2179"},"modified":"2025-06-03T13:44:21","modified_gmt":"2025-06-03T13:44:21","slug":"%f0%9f%9a%80-neurobiostand-at-adpd-2025-%f0%9f%a7%a0","status":"publish","type":"post","link":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/%f0%9f%9a%80-neurobiostand-at-adpd-2025-%f0%9f%a7%a0\/","title":{"rendered":"\ud83d\ude80 NEuroBioStand at ADPD 2025! \ud83e\udde0"},"content":{"rendered":"

We\u2019re excited to announce that NEuroBioStand will be actively participating in the #<\/span>ADPD2025<\/a> \u2013 International Conference on Alzheimer\u2019s and Parkinson\u2019s Diseases! Our consortium is dedicated to advancing biomarker standardization in neurodegenerative diseases, and we can\u2019t wait to share our latest research through oral presentations and posters.<\/p>\n

\ud83d\udccc Where to find us at ADPD:<\/p>\n

\ud83d\udde3 Oral Presentations
\n\ud83d\udd39 Wed, 02.04.2025 – Plenary Lecture – PLASMA BIOMARKERS FOR DEMENTIAS IN THE ERA OF DISEASE MODIFYING THERAPIES [Charlotte Teunissen<\/a>]
\n\ud83d\udd39\u00a0Sat, 05.04.2025 – Symposium FLUID BIOMARKERS AND IMAGING IN AD, PD, LBD 02 – A STEPWISE APPROACH USING PLASMA PTAU217 AND NFL AS AN ALTERNATIVE TO CSF ANALYSIS [Sylvain Lehmann<\/a>]
\n\ud83d\udd39 On-Demand Oral (SHIFT 01-645) NEUROBIOSTAND: A EUROPEAN CONSORTIUM TO STANDARDISE P-TAU MEASUREMENTS IN PLASMA \u2013 [Chiara Giangrande<\/a>, project coordinator]
\n\ud83d\udd39 On-Demand Oral (SHIFT 01-367) CSF PROGRANULIN CORRELATES WITH ALZHEIMER DISEASE AND CSF AMYLOID STATUS \u2013 [Peter K\u00f6rtv\u00e9lyessy, WP leader Impact]
\n\ud83d\udd39 On-Demand Oral (SHIFT 02-340) PLASMA NFL, GFAP, A\u039240\/42, PTAU181, AND PTAU217 FAIL TO DETECT LEWY BODY PATHOLOGY IN COGNITIVELY IMPAIRED INDIVIDUALS [Sylvain Lehmann<\/a>]<\/p>\n

\ud83d\udcdc Poster Presentations
\n\ud83d\udd39 (SHIFT 02-493) QUANTIFICATION OF NF-L IN CEREBROSPINAL FLUID BY MASS SPECTROMETRY: TOWARDS IMPLEMENTATION OF A REFERENCE MEASUREMENT PROCEDURE \u2013 [Luise Luckau<\/a>, WP leader on NfL activities]
\n\ud83d\udd39 (SHIFT 01-376): NEWLY DEVELOPED LC-MS\/MS ASSAY FOR NEUROFILAMENT-LIGHT CHAIN (NFL) QUANTIFICATION: HEAD-TO-HEAD COMPARISON WITH IMMUNOASSAYS \u2013 [Salom\u00e9 Coppens<\/a>]
\n\ud83d\udd39 (SHIFT 01-645) NEUROBIOSTAND: A EUROPEAN CONSORTIUM TO STANDARDISE P-TAU MEASUREMENTS IN PLASMA \u2013 [Chiara Giangrande<\/a>, project coordinator]<\/p>\n

\ud83d\udccd NEuroBioStand Consortium Meeting
\nIn addition to our conference participation, the NEuroBioStand Consortium will meet in Vienna at Arcotel to align on our next steps in biomarker standardization and future collaborations.<\/p>\n

\ud83e\udd1d Meet the Project Coordinator!
\nInterested in learning more about NEuroBioStand and exploring potential collaborations? Our Project Coordinator, Dr. Chiara Giangrande<\/a>, will be available for discussions throughout the conference. You can connect with her at our presentations, during the poster sessions, or reach out in advance to schedule a meeting.
\nJoin us at ADPD for insightful discussions and let\u2019s advance biomarker research together! Looking forward to seeing you in Vienna.
\n#<\/span>NEuroBioStand<\/a> #<\/span>ADPD2025<\/a> #<\/span>Neurodegeneration<\/a> #<\/span>Biomarkers<\/a> AD\/PD – Advances in Science & Therapy<\/a>
\nEURAMET – The European Association of National Metrology Institutes<\/a> #<\/span>metrology<\/a>
\n#<\/span>measurementscience<\/a>
\n#<\/span>EUpartnership<\/a>
\n#<\/span>EUfunded<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

We\u2019re excited to announce that NEuroBioStand will be actively participating in the #ADPD2025 \u2013 International Conference on Alzheimer\u2019s and Parkinson\u2019s Diseases! Our consortium is dedicated to advancing biomarker standardization in neurodegenerative diseases, and we can\u2019t wait to share our latest research through oral presentations and posters. \ud83d\udccc Where to find us at ADPD: \ud83d\udde3 Oral […]<\/p>\n","protected":false},"author":46,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-2179","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-uncategorized","7":"entry","8":"gs-1","9":"gs-odd","10":"gs-even","11":"gs-featured-content-entry"},"acf":[],"_links":{"self":[{"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/posts\/2179"}],"collection":[{"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/comments?post=2179"}],"version-history":[{"count":3,"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/posts\/2179\/revisions"}],"predecessor-version":[{"id":2182,"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/posts\/2179\/revisions\/2182"}],"wp:attachment":[{"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/media?parent=2179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/categories?post=2179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/projects.lne.eu\/jrp-neurobiostand\/wp-json\/wp\/v2\/tags?post=2179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}